1 |
R. Chatterjee & J. Chatterjee. (2020). ROS and oncogenesis with special reference to EMT and stemness. Eur J Cell Biol, 99, 151073.
DOI
|
2 |
J. X. Jiang et al. (2017). Rac1 signaling regulates cigarette smoke-induced inflammation in the lung via the Erk1/2 MAPK and STAT3 pathways. Biochim Biophys Acta, 1863(7), 1778-1788. DOI : 10.1016/j.bbadis.2017.04.013
DOI
|
3 |
T. H. Chu. (2014). Celecoxib suppresses hepatoma stemness and progression by up-regulating PTEN. Oncotarget, 5, 1475-1490.
DOI
|
4 |
K. H. Yoo, Y. S. Kim & S. S. Sheen. (2011). Prevalence of chronic obstructive pulmonary disease in Korea: the fourth Korean National Health and Nutrition Examination Survey, 2008. Respirology, 16(4), 659-665.
DOI
|
5 |
J. C. Hogg, F Chu & S Utokaparch. (2004). The nature of small-airway obstruction in chronic obstructive pulmonary disease. New England Journal of Medicine, 350(26), 2645-2653.
DOI
|
6 |
P. J. Barnes. (2009). The cytokine network in chronic obstructive pulmonary disease. American Journal of Respiratory Cell and Molecular Biology, 41(6), 631-638.
DOI
|
7 |
P. J. Barnes. (2008). Immunology of asthma and chronic obstructive pulmonary disease. Nature Reviews Immunology, 8(3), 183-192.
DOI
|
8 |
G. G. Brusselle, G. F. Joos & K. R. Bracke. (2011). New insights into the immunology of chronic obstructive pulmonary disease. The Lancet, 378(9795), 1015-1026.
DOI
|
9 |
P Venkatesan. (2011). The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials, 32, 3794-3806.
DOI
|
10 |
M. Rincon & C. G. Irvin. (2012). Role of IL-6 in asthma and other inflammatory pulmonary diseases. International Journal of Biological Sciences, 8(9), 1281-1290.
DOI
|
11 |
D. Bartis, N. Mise, R. Y. Mahida, O. Eickelberg & D. R. Thickett. (2014). Epithelial- mesenchymal transition in lung development and disease: does it exist and is it important? Thorax, 69, 760-65.
DOI
|
12 |
A. Soltani, S. Sohal. S. Weston, R. Wood-Baker & E. H. Walters. (2012). Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS ONE, 7(6), e39736.
DOI
|
13 |
M. Rincon & C. G. Irvin. (2012). Role of IL-6 in asthma and other inflammatory pulmonary diseases. International Journal of Biological Sciences, 8(9), 1281-1290.
DOI
|
14 |
N. Kaosia, S. Sukhwinder Singh, P Gregory, P Rahul & H. W. Eugene. (2014). Epithelial-mesenchymal transition as a fundamental underlying pathogenic process in COPD airways: fibrosis, remodeling and cancer. Expert Rev Respir Med, 8(5), 547-559.
DOI
|
15 |
Q. Wang, Y. Wang, Y. Zhang, Y. Zhang & W. Xiao. (2013). The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir. Res, 14, 67.
DOI
|
16 |
A. Butler, G. M. Walton & E. Sapey. (2018). Neutrophilic inflammation in the pathogenesis of chronic obstructive pulmonary disease. COPD: Journal of Chronic Obstructive Pulmonary Disease, 15(4), 392-404.
DOI
|
17 |
M. Javier, N. Rafael, J. Gustavo, P. Teresa, S. Adela & R. Mercedes. (2012). Sphingosine-1-phosphate is increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal transition. Thorax, 67(2), 147-156.
DOI
|
18 |
D. Chakroborty. (2011). Dopamine stabilizes tumor blood vessels by up-regulating angiopoietin 1 expression in pericytes and Kruppel-like factor-2 expression in tumor endothelial cells. Proc. Natl. Acad. Sci. USA, 108, 20730-20735.
DOI
|
19 |
V. M. Keatings, P. D. Collins, D. M. Scott & P. J. Barnes. (1996). Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma. American Journal of Respiratory and Critical Care Medicine, 153(2), 530-534.
DOI
|
20 |
J. C. Hogg & W. Timens. (2009). The pathology of chronic obstructive pulmonary disease. Annual Review of Pathology: Mechanisms of Disease, 4(1), 435-459.
DOI
|
21 |
I. Tsiligianni, E. Metting, T. van der Molen, N. Chavannes & J. Kocks. (2016). Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG. NPJ Prim Care Respir Med, 26. 16040.
DOI
|
22 |
J. Milara, T. Peiro, A. Serrano & J. Cortijo. (2013). Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke. Thorax, 68, 410-420.
DOI
|
23 |
D. G. Menter, R. L. Schilsky & R. N. DuBois. (2010). Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin. Cancer Res, 16, 1384-1390.
DOI
|
24 |
M. Xie, X Liu, X Cao, M Guo & X Li. (2020). Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res, 21(1), 49.
DOI
|